** Shares of Shanghai Junshi Biosciences 1877.HK drop 9.8% to HK$25.85, on course to snap four straight session of gains
** Shanghai-listed stock 688180.SS falls 2.7% to 37.60 yuan, on track for the biggest one-day pct decline since May 26, if losses hold
** The Chinese biopharmaceutical group plans to sell 41 million new H-shares to third-party investors, raising HK$1.04 billion ($132.51 million) for commercialising potential new-generation drugs and for investment in R&D technologies
** The new H-shares will be issued at HK$25.35 each, or 11.5% discount to Thursday's close of HK$28.65 per share
** Hong Kong's healthcare index .HSCIH and Hang Seng Biotech Index .HSHKBIO both climb 1.1%
** YTD, Hong Kong stock up 137.5%, Shanghai shares up 38.4%
($1 = 7.8487 Hong Kong dollars)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。